Insider Selling: Trupanion (NASDAQ:TRUP) COO Sells $78,149.07 in Stock

Trupanion, Inc. (NASDAQ:TRUP) COO John Gallagher sold 3,603 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $21.69, for a total value of $78,149.07. Following the sale, the chief operating officer owned 33,065 shares of the company’s stock, valued at approximately $717,179.85. This trade represents a 9.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link.

Trupanion Stock Performance

NASDAQ TRUP opened at $21.46 on Thursday. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73. The stock’s 50 day simple moving average is $24.68 and its 200-day simple moving average is $29.92. The company has a market cap of $936.09 million, a PE ratio of 36.37 and a beta of 1.45. Trupanion, Inc. has a 1-year low of $21.16 and a 1-year high of $57.88.

Trupanion (NASDAQ:TRUP) last issued its quarterly earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, topping the consensus estimate of $0.07 by $0.04. Trupanion had a return on equity of 6.87% and a net margin of 1.74%.The firm had revenue of $384.05 million during the quarter, compared to analysts’ expectations of $379.77 million. During the same period in the previous year, the business earned ($0.03) earnings per share. The firm’s revenue for the quarter was up 12.3% on a year-over-year basis. As a group, equities research analysts anticipate that Trupanion, Inc. will post 0.53 EPS for the current fiscal year.

Analysts Set New Price Targets

TRUP has been the subject of a number of recent research reports. Piper Sandler reduced their target price on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a research note on Monday. Bank of America lowered their target price on Trupanion from $63.00 to $59.00 and set a “buy” rating on the stock in a report on Tuesday, April 14th. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Finally, Stifel Nicolaus cut their price target on Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a report on Tuesday, March 31st. Two analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $42.25.

Hedge Funds Weigh In On Trupanion

A number of institutional investors have recently bought and sold shares of the company. Royal Bank of Canada grew its stake in shares of Trupanion by 60.6% in the 1st quarter. Royal Bank of Canada now owns 29,763 shares of the financial services provider’s stock valued at $1,109,000 after buying an additional 11,233 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Trupanion by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 19,603 shares of the financial services provider’s stock valued at $731,000 after buying an additional 858 shares during the period. Millennium Management LLC raised its position in shares of Trupanion by 73.5% during the 1st quarter. Millennium Management LLC now owns 267,976 shares of the financial services provider’s stock valued at $9,987,000 after buying an additional 113,490 shares during the period. Invesco Ltd. lifted its holdings in Trupanion by 35.1% in the second quarter. Invesco Ltd. now owns 187,749 shares of the financial services provider’s stock valued at $10,392,000 after acquiring an additional 48,781 shares during the last quarter. Finally, Gabelli Funds LLC acquired a new position in Trupanion in the second quarter valued at approximately $249,000.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.